2Curt D,Jacrson T,Barry R,et al .Major outcomes in high riskhypertensive patients randomized to angiotensin converting enzymeinhibitor or calcium channel blocker versus diuretic. Theantihypertensive and lipid lowering treatment to prevent heartattack trial(ALLHAT)[J].JAMA,2002,288(23):2981- 2997.
3Yis,Kim TE,Yoon SH,et al .Pharmacokinetic interaction of fimasartan,a new angiotensin Ⅱ receptor antagonist,with amlodipinein healthy volunteers[J].Journal of Cardiovascular Pharmacology,2011,57:6.
